EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The integrated stress response in cancer: mechanisms of tumor adaptation and therapeutic targeting

Elias Maldonado iD, Emily McIsaac iD, Josie Ursini-Siegel iD

Biochemical Society Transactions · 2026

DOI: 10.1042/bst20250133 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemical Society Transactions, 2026. Verfasst von Elias Maldonado und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical and Translational Research, McGill University, Montreal, Canada. Hauptthemen laut MEDLINE: Integrated Stress Response, Neoplasms, Adaptation, Physiological, Stress, Physiological. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research (CIHR), Cancer Research Society (CRS), FRQ | Santé (FRQS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer cells face continual stressors, which they must overcome to proliferate and survive in the body. Under these conditions, essential biochemical pathways are disrupted, contributing to various stress responses that either promote adaptation and survival or eventual cell death. The evolutionarily conserved integrated stress response (ISR) is a key adaptive mechanism that transiently rewires the transcriptome and translatome in response to various stressors. While the ISR is activated in healthy cells under moderate stress, cancers especially rely on this pathway to overcome harsh conditions experienced during tumor growth and metastasis. We explore the pro-tumorigenic role of the ISR, along with the upstream stress-sensing kinases that activate it. These include protein kinase R-like endoplasmic reticulum kinase, general control non-derepressible 2, double-stranded RNA-dependent protein kinase, and heme-regulated eukaryotic translation initiation factor 2α kinase (HRI), which initiate an ISR in response to diverse stressors by phosphorylating their shared substrate, eukaryotic initiation factor-2α. An in-depth understanding of the pro-survival functions of the ISR and the contexts in which it is pro-tumorigenic is necessary to leverage the ISR as a therapeutic strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Integrated Stress ResponseNeoplasmsAdaptation, PhysiologicalStress, PhysiologicalHumansAnimalsEukaryotic Initiation Factor-2Signal Transduction

Stichwörter der Autor:innen

ATF4Integrated Stress ResponsecancereIF2alpha

Substanzen

Eukaryotic Initiation Factor-2

Autor:innen und Institutionen

  • Division of Clinical and Translational Research, McGill University, Montreal, Canada.
  • Lady Davis Institute for Medical Research, McGill University, Montreal, Canada.
  • Gerald Bronfman Department of Oncology, McGill University, Montreal, Canada.
  • Department of Biochemistry, McGill University, Montreal, Canada.

ORCID-Profile: Elias Maldonado, Emily McIsaac, Josie Ursini-Siegel

Förderung

  • Canadian Institutes of Health Research (CIHR)
  • Cancer Research Society (CRS)
  • FRQ | Santé (FRQS)

Zitieren

APA

Maldonado, E., McIsaac, E., & Ursini-Siegel, J. (2026). The integrated stress response in cancer: mechanisms of tumor adaptation and therapeutic targeting. Biochemical Society Transactions. https://doi.org/10.1042/bst20250133

Vancouver

Maldonado E, McIsaac E, Ursini-Siegel J. The integrated stress response in cancer: mechanisms of tumor adaptation and therapeutic targeting. Biochemical Society Transactions. 2026. doi:10.1042/bst20250133

BibTeX
@article{Maldonado2026,
  author = {Maldonado, Elias and McIsaac, Emily and Ursini-Siegel, Josie},
  title = {The integrated stress response in cancer: mechanisms of tumor adaptation and therapeutic targeting},
  journal = {Biochemical Society Transactions},
  year = {2026},
  doi = {10.1042/bst20250133}
}
Kostenlos starten →